Cellular Regulation of Amyloid Formation in Aging and DiseaseStroo, E., Koopman, M., Nollen, E. A. A. & Mata-Cabana, A., 14-Feb-2017, In : Frontiers in Neuroscience. 11, 17 p., 64.
Research output: Contribution to journal › Review article › Academic › peer-review
As the population is aging, the incidence of age-related neurodegenerative diseases, such as Alzheimer and Parkinson disease, is growing. The pathology of neurodegenerative diseases is characterized by the presence of protein aggregates of disease specific proteins in the brain of patients. Under certain conditions these disease proteins can undergo structural rearrangements resulting in misfolded proteins that can lead to the formation of aggregates with a fibrillar amyloid-like structure. Cells have different mechanisms to deal with this protein aggregation, where the molecular chaperone machinery constitutes the first line of defense against misfolded proteins. Proteins that cannot be refolded are subjected to degradation and compartmentalization processes. Amyloid formation has traditionally been described as responsible for the proteotoxicity associated with different neurodegenerative disorders. Several mechanisms have been suggested to explain such toxicity, including the sequestration of key proteins and the overload of the protein quality control system. Here, we review different aspects of the involvement of amyloid-forming proteins in disease, mechanisms of toxicity, structural features, and biological functions of amyloids, as well as the cellular mechanisms that modulate and regulate protein aggregation, including the presence of enhancers and suppressors of aggregation, and how aging impacts the functioning of these mechanisms, with special attention to the molecular chaperones.
|Number of pages||17|
|Journal||Frontiers in Neuroscience|
|Publication status||Published - 14-Feb-2017|
- neurodegeneration, protein aggregation, amyloid, protein quality control, SERF, FAMILIAL ALZHEIMERS-DISEASE, PATHOLOGICAL ALPHA-SYNUCLEIN, CHAPERONE-MEDIATED AUTOPHAGY, AMYOTROPHIC-LATERAL-SCLEROSIS, UNFOLDED PROTEIN RESPONSE, EARLY-ONSET PARKINSONISM, HEAT-SHOCK PROTEINS, LIFE-SPAN EXTENSION, A-BETA PRIONS, IN-VITRO